Maxivision Launches 10 Super Speciality Eye Centres in Chennai

Maxivision Launches 10 Super Speciality Eye Centres in Chennai

India Pharma Outlook Team | Friday, 01 August 2025

 Maxivision Super Speciality Eye Hospitals

Maxivision Super Speciality Eye Hospitals (‘Maxivision’), one of India's fastest-growing eye care providers, announced its strategic expansion in Chennai with the launch of 10 eye hospitals/vision centres across Chennai.

The hospital and vision centre was inaugurated by Mr. Mahendra Singh Dhoni (MS Dhoni) - former Team India skipper, in the presence of Dr. GSK Velu, Chairman & Managing Director of Maxivision Eye Hospitals group and Dr. Kasu Prasad Reddy Co- Chairman of Maxivision Eye Hospitals group. Dr. B Ganesh, Clinical & Academic Director, Maxivision Eye Hospitals, Chennai & Dr. Shibu Varkey Regional Clinical Director for the rest of Tamilnadu, also participated in the proceedings.

With an investment of Rs100 crores, Maxivision aims to expand its network across Chennai, starting with this launch. Maxivision already operates eye hospitals in Trichy, Madurai, Salem, Tanjore, Kumbakonam, Perambalur, and wishes to expand into all districts/towns across Tamil Nadu to fulfil its mission to deliver advanced, affordable, and community-centric eye care across Chennai & Tamil Nadu.

Also Read: Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care

MS Dhoni also launched SiLK Elita- Chennai’s first flapless, blade-free laser vision correction procedure- offering a pain-free experience, next-day recovery, and minimal dry-eye risk at its Anna Nagar premises.

The hospitals are also equipped for robotic femto-laser cataract surgery, advanced diagnostics for retina, cornea, and glaucoma, diabetic retinopathy treatment, paediatric ophthalmology, and corneal transplantation. This strategic expansion directly addresses the city’s escalating burden of cataract, glaucoma, and lifestyle-driven vision disorders.

Dr GSK Velu, Chairman & Managing Director of Maxivision Super Speciality Eye Hospitals, said, “It is long-term overdue for us, and we are pleased to arrive in Chennai, where Maxivision’s corporate headquarters is based. Today marks a strategic step forward in expanding our footprint in the high-demand, high-potential market of Chennai."

"Our Chennai grand launch by MS Dhoni is aligned with our long-term vision to build a strong, decentralised ophthalmic infrastructure that can effectively address the growing burden of cataract, retina, glaucoma, and several other vision disorders. It also strengthens our talent ecosystem by creating avenues for ophthalmologists, optometrists, and allied professionals to thrive within their local communities. With this expansion, Maxivision reinforces its commitment to shaping the future of eye care delivery in Chennai and Tamil Nadu,” he added.

Dr. Shibu Varkey, Regional Medical Director of Maxivision Super Speciality Eye Hospitals, added, “Our mission is to bring advanced, accessible eye care to underserved and middle-income communities across Tamil Nadu. With state-of-the-art technology and a strong focus on early diagnosis and preventive care, we aim to reduce the region’s long-term disease burden and establish Tamil Nadu as a hub for clinical excellence and ophthalmic skill development. The centres will serve as the first point of contact for early diagnosis of conditions like diabetic retinopathy, cataract, and glaucoma, helping reduce the long-term disease burden through timely intervention and education.”

Also Read: Strategic finance for pharmaceutical innovation and stability

Prof . Dr. B Ganesh, Clinical & Academic Director, Maxivision Eye Hospitals, said, “The launch of 10 Super Speciality Eye Hospitals across Chennai marks a significant milestone in our mission to make world-class eye care accessible to every corner of the Greater Chennai region. We will start several academic initiatives to train Ophthalmologists, Optometrists , Counsellors & Para medical professionals as part of CSR initiatives across Tamilnadu "

Mr. Mahendra Singh Dhoni, Captain of Chennai Super Kings and former Captain of Team India, added, “It gives me great joy to be a part of Maxivision’s journey as they expand their footprint in Chennai with the launch of these centres across Chennai. Vision is something we often take for granted -until it begins to fade. What I truly admire about Maxivision is its commitment to delivering cutting-edge, blade-free eye treatments that are both accessible and affordable. With innovations like SiLK Elita, they are helping people see life more clearly, safely, and confidently. I am happy to have inaugurated these ten centres in my favourite city of Chennai, benefiting the people of Chennai.”

Tamil Nadu faces a mounting ophthalmic burden, with Chennai at its epicentre-reporting a cataract prevalence of 40–60%, which doubles the state average, driven by a dense, ageing population and rising lifestyle diseases like diabetes and hypertension. Post-COVID, pediatric vision issues, dry eye, keratoconus, and asthenopia have surged due to excessive screen time.

As the “Medical Capital of India,” Chennai attracts patients from across South India, Sri Lanka, and Southeast Asia, offering unmatched access to skilled ophthalmologists. Maxivision’s strategic expansion brings cutting-edge eye care closer to these high-need populations, boosting timely intervention, strengthening regional infrastructure, and fostering healthcare employment across Chennai, Andhra Pradesh, Kerala, and Telangana.

Maxivision Super Speciality Eye Hospitals signed a Memorandum of Understanding with the Government of Tamil Nadu last year to launch Project Velicham, committing Rs 400 crores over four years to expand eye care infrastructure across the state. As part of this initiative, Maxivision will set up 30-plus eye hospitals and 100-plus vision centres. The project aims to deliver advanced, affordable eye care to underserved regions, while also generating employment and enhancing ophthalmic training and research in Tamil Nadu.

Source: Press Release

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.